RA Comorbidity: Bone Health in Men and African Americans

Conditions:		Rheumatoid Arthritis
Purpose:		The objective of the proposed study is to assess bone health and determinants of bone health among select subpopulations of rheumatoid arthritis patients.
Study Summary:		The overall hypothesis of this study is that osteopenia and/or osteoporosis are common among African Americans and men with rheumatoid arthritis and there are identifiable genetic and environmental factors contributing to the pathogenesis of bone loss in these groups. The Specific Aims of the study are to: 1. Determine baseline hip and lumbar spine bone density (BMD) values and osteopenia/osteoporosis prevalence among African American men and women with early RA and among male veterans with established RA. 2. Identify environmental factors and candidate alleles, which confer increased risk of reduced baseline BMD loss over time among African American men and women with early RA and among male veterans with established RA.
Criteria:		Inclusion Criteria: - Clinical diagnosis of rheumatoid arthritis per ACR guidelines Exclusion Criteria: - Patients with diagnosis > 2yrs (CLEAR study)
NCT ID:		NCT00595894
Primary Contact:		Principal Investigator Ted R Mikuls, MD, MSPH University of Nebraska Ted R Mikuls, MD, MSPH Phone: 402-559-7258 Email: tmikuls@unmc.edu
Backup Contact:		N/A
Location Contact:		Omaha, Nebraska 68105 United States Ted R Mikuls, MD, MSPH Phone: 402-559-8846 Email: tmikuls@unmc.edu Site Status: Recruiting

Click here to see:

Data Source:		ClinicalTrials.gov
Date Processed:		May 19, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.